A combination of five methylation markers (ONECUT2, MEIS1, OSR1, OTX1, and SIM2) resulted in a bladder cancer prediction model, with a sensitivity of 85% and a specificity of 87% [97]. The gene discussed is MEIS1; the disease is urinary bladder cancer.